Linked-evidence model of qualitative G6PD testing
Viewed:
217
This model compares the number of severe haemolysis events and Plasmodium vivax recurrences within 6 months of treatment for three scenarios; low-dose primaquine (PQ) provided to all patients (baseline), low-dose PQ provided to patients who test G6PD-normal using a qualitative G6PD test and intermediate-dose PQ provided to patients to test G6PD-normal on a qualitative G6PD test. In the G6PD testing scenarios, patients who test G6PD-deficient are provided 8-week PQ.
The model is created in the TreeAge Pro Healthcare (2024) software and represents a theoretical population of 10,000 male P. vivax patients with a 1% prevelance of G6PD-deficiency.
Research areas
Mathematical modelling
Mosquito-borne disease
G6PD test
Infectious diseases
Public
health
Biostatistics
Plasmodium vivax
Malaria
Diagnostics
Radical cure
G6PD deficiency
Cite this collection
Gatton, Michelle; (2024): Linked-evidence model of qualitative G6PD testing. Queensland University of Technology. (Software) https://doi.org/10.25912/RDF_1723181452844
Related information
Centre for Immunology and Infection Control, QUT
https://research.qut.edu.au/ciic/
Licence
Copyright
© Queensland University of Technology, 2024.
Data file types
File format is .trex and requires the TreeAge Pro Healthcare.
Dates of development
From 2023-10-10 to 2024-02-06
Connections
Has association with
Has chief investigator
Contacts
Name: Professor Michelle Gatton
Email: m.gatton@qut.edu.au
Other
Date record created:
2024-06-22T10:51:22
Date record modified:
2024-08-09T15:33:35
Record status:
Published - Open Access